Journal for ImmunoTherapy of Cancer (Nov 2021)
960 Randomized multicenter study of neoadjuvant chemoradiation therapy (CRT) alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic cancer
Abstract
No abstracts available.